Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482571 · ClinicalTrials.gov registry record · NA
Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02482571 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 25 participants.
The verdict
NCT02482571, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary objective of this research is to measure changes in neurochemical concentrations during stimulation of the primary visual cortex, in both conditions of normoxia (normal oxygen availability) and induced mild hypoxia (reduced oxygen availability).
Interventions
- DEVICE Mild Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-08-13 |
| Est. Completion | 2016-09-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02482571
The ClinicalTrials.gov registry entry for NCT02482571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mild Hypoxia is the first listed.
NCT02482571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02482571 about?
NCT02482571 is a clinical study titled "Metabolic Changes in the Activated Human Visual Cortex During Mild Hypoxia". The primary objective of this research is to measure changes in neurochemical concentrations during stimulation of the primary visual cortex, in both conditions of normoxia (normal oxygen availability) and induced mild hypoxia (reduced oxygen availability).
What is the current status of trial NCT02482571?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-08-13. Estimated completion is 2016-09-26.
What interventions are being tested in trial NCT02482571?
The interventions under investigation include: Mild Hypoxia (DEVICE).
Who is sponsoring clinical trial NCT02482571?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.